Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Aug;2(3):239-49.
doi: 10.1517/14622416.2.3.239.

Gene identification in Alzheimer's disease

A M Saunders  1
Affiliations
Review

Gene identification in Alzheimer's disease

A M Saunders. Pharmacogenomics. 2001 Aug.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in the elderly population. Three genes have been identified that cause the less common early-onset, familial cases of the disease: the amyloid precursor (APP) protein gene on chromosome 21, the presenilin 1 (PSEN1) gene on chromosome 14 and the presenilin 2 (PSEN2) gene on chromosome 1. Mutations in these genes account for << 2% of the total number of AD cases. More than 50% of the cases are late-onset and related to the apolipoprotein E (APOE) gene on chromosome 19. The apolipoprotein E locus is a susceptibility gene, with polymorphisms affecting both risk and age-of-onset of the disease. Intense efforts are underway to identify additional susceptibility genes and promising regions on chromosomes 6, 9, 10 and 12 have been identified through whole genome scans. In addition, the genetic basis of several other non-AD inherited dementias has been unravelled. Discovery of the genetically relevant genes will aid in the elucidation of the pathogenesis of AD. The high-throughput tools of pharmacogenomics for gene-to-function-to-target studies can provide a quicker means of monitoring how mutations and polymorphisms affect model systems' adaptations to the altered genes, possibly identifying signal transduction or biochemical pathways. This relevant information can then be used for drug target selection and pharmacogenetics.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

LinkOut - more resources